182 related articles for article (PubMed ID: 35486397)
1. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration.
Illán-Gala I; Nigro S; VandeVrede L; Falgàs N; Heuer HW; Painous C; Compta Y; Martí MJ; Montal V; Pagonabarraga J; Kulisevsky J; Lleó A; Fortea J; Logroscino G; Quattrone A; Quattrone A; Perry DC; Gorno-Tempini ML; Rosen HJ; Grinberg LT; Spina S; La Joie R; Rabinovici GD; Miller BL; Rojas JC; Seeley WW; Boxer AL
JAMA Netw Open; 2022 Apr; 5(4):e229588. PubMed ID: 35486397
[TBL] [Abstract][Full Text] [Related]
2. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
[TBL] [Abstract][Full Text] [Related]
3. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome.
VandeVrede L; La Joie R; Thijssen EH; Asken BM; Vento SA; Tsuei T; Baker SL; Cobigo Y; Fonseca C; Heuer HW; Kramer JH; Ljubenkov PA; Rabinovici GD; Rojas JC; Rosen HJ; Staffaroni AM; Boeve BF; Dickerson BC; Grossman M; Huey ED; Irwin DJ; Litvan I; Pantelyat AY; Tartaglia MC; Dage JL; Boxer AL
JAMA Neurol; 2023 May; 80(5):495-505. PubMed ID: 37010841
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
7. Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome.
Parmera JB; de Godoi Carneiro C; de Almeida IJ; de Oliveira MCB; Barbosa PM; Studart-Neto A; Ono CR; Nitrini R; Buchpiguel CA; Barbosa ER; Brucki SMD; Coutinho AM
Mov Disord Clin Pract; 2024 Mar; 11(3):238-247. PubMed ID: 38155526
[TBL] [Abstract][Full Text] [Related]
8. Clinicoradiologic and Neuropathologic Evaluation of Corticobasal Syndrome.
Shir D; Pham NTT; Botha H; Koga S; Kouri N; Ali F; Knopman DS; Petersen RC; Boeve BF; Kremers WK; Nguyen AT; Murray ME; Reichard RR; Dickson DW; Graff-Radford N; Josephs KA; Whitwell J; Graff-Radford J
Neurology; 2023 Jul; 101(3):e289-e299. PubMed ID: 37268436
[TBL] [Abstract][Full Text] [Related]
9. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology.
Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA
Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093
[TBL] [Abstract][Full Text] [Related]
10. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
Mimuro M; Yoshida M
Neuropathology; 2020 Feb; 40(1):57-67. PubMed ID: 31515852
[TBL] [Abstract][Full Text] [Related]
11. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
[TBL] [Abstract][Full Text] [Related]
12. Brainstem Biomarkers of Clinical Variant and Pathology in Progressive Supranuclear Palsy.
Grijalva RM; Pham NTT; Huang Q; Martin PR; Ali F; Clark HM; Duffy JR; Utianski RL; Botha H; Machulda MM; Weigand SD; Ahlskog JE; Dickson DW; Josephs KA; Whitwell JL
Mov Disord; 2022 Apr; 37(4):702-712. PubMed ID: 34970796
[TBL] [Abstract][Full Text] [Related]
13. MRI evaluation of progressive supranuclear palsy: differentiation from Parkinson's disease and multiple system atrophy.
Eraslan C; Acarer A; Guneyli S; Akyuz E; Aydin E; Colakoglu Z; Kitis O; Calli MC
Neurol Res; 2019 Feb; 41(2):110-117. PubMed ID: 30373485
[TBL] [Abstract][Full Text] [Related]
14. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ
J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Susceptibility in Progressive Supranuclear Palsy Variants, Parkinson's Disease, and Corticobasal Syndrome.
Satoh R; Weigand SD; Pham NTT; Ali F; Arani A; Senjem ML; Jack CR; Whitwell JL; Josephs KA
Mov Disord; 2023 Dec; 38(12):2282-2290. PubMed ID: 37772771
[TBL] [Abstract][Full Text] [Related]
16. Voxel-based morphometry in autopsy proven PSP and CBD.
Josephs KA; Whitwell JL; Dickson DW; Boeve BF; Knopman DS; Petersen RC; Parisi JE; Jack CR
Neurobiol Aging; 2008 Feb; 29(2):280-9. PubMed ID: 17097770
[TBL] [Abstract][Full Text] [Related]
17. Midbrain morphology in idiopathic normal pressure hydrocephalus: A progressive supranuclear palsy mimic.
Constantinides VC; Paraskevas GP; Velonakis G; Toulas P; Stefanis L; Kapaki E
Acta Neurol Scand; 2020 Apr; 141(4):328-334. PubMed ID: 31856297
[TBL] [Abstract][Full Text] [Related]
18. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
20. Imaging-pathologic correlation in corticobasal degeneration.
Tokumaru AM; Saito Y; Murayama S; Kazutomi K; Sakiyama Y; Toyoda M; Yamakawa M; Terada H
AJNR Am J Neuroradiol; 2009 Nov; 30(10):1884-92. PubMed ID: 19833793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
